• Issue

    Hepatology: Volume 40, Issue 6

    1237-1483
    December 2004
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Editor's Corner

Free Access

Who owns the data?

Andres T. Blei M.D., 
  • Page: 1237
  • First Published: 24 November 2004

Hepatolgy Highlights

Free Access

Hepatology highlights

Elwyn Elias, 
  • Pages: 1238-1239
  • First Published: 24 November 2004

News From NIH

Free Access

Action plan for liver disease research

Jay H. Hoofnagle M.D., 
  • Page: 1240
  • First Published: 24 November 2004

Concise Review in Mechanisms of Disease

Free Access

Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis

Tin K. Mao,  Paul A. Davis,  Joseph A. Odin,  Ross L. Coppel,  M. Eric Gershwin, 
  • Pages: 1241-1248
  • First Published: 24 November 2004

Editorial

Free Access

Tinkering and tailoring with HCV therapy: Can we get away with less?†

Amany Zekry,  Keyur Patel,  Andrew Muir,  John G. McHutchison, 
  • Pages: 1249-1251
  • First Published: 24 November 2004
Free Access

Probing Prometheus: Fat fueling the fire?†

Geoffrey C. Farrell M.D., FRACP, 
  • Pages: 1252-1255
  • First Published: 24 November 2004
Free Access

Mesenchymal stem cells: An alternative source of hepatocytes?†

Hélène Gilgenkrantz M.D., Ph.D., 
  • Pages: 1256-1259
  • First Published: 24 November 2004

Rapid Communication

Free Access

Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: A pilot study

Olav Dalgard,  Kristian Bjøro,  Kjell Block Hellum,  Bjørn Myrvang,  Ståle Ritland,  Kjell Skaug,  Nils Raknerud,  Helge Bell, 
  • Pages: 1260-1265
  • First Published: 24 November 2004

Original Articles

Free Access

Transcription factor HNF-6/OC-1 inhibits the stimulation of the HNF-3α/Foxa1 gene by TGF-β in mouse liver

Nicolas Plumb-Rudewiez,  Frédéric Clotman,  Hélène Strick-Marchand,  Christophe E. Pierreux,  Mary C. Weiss,  Guy G. Rousseau,  Frédéric P. Lemaigre, 
  • Pages: 1266-1274
  • First Published: 24 November 2004
Free Access

In vitro hepatic differentiation of human mesenchymal stem cells

Kuan-Der Lee,  Tom Kwang-Chun Kuo,  Jacqueline Whang-Peng,  Yu-Fen Chung,  Ching-Tai Lin,  Shiu-Huey Chou,  Jim-Ray Chen,  Yi-Peng Chen,  Oscar Kuang-Sheng Lee, 
  • Pages: 1275-1284
  • First Published: 24 November 2004
Free Access

IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes

Angela M. Valverde,  Isabel Fabregat,  Deborah J. Burks,  Morris F. White,  Manuel Benito, 
  • Pages: 1285-1294
  • First Published: 24 November 2004
Free Access

PGE1-induced NO reduces apoptosis by D-galactosamine through attenuation of NF-κB and NOS-2 expression in rat hepatocytes

Emilio Siendones,  Dalia Fouad,  María José M. Díaz-Guerra,  Manuel de la Mata,  Lisardo Boscá,  Jordi Muntané, 
  • Pages: 1295-1303
  • First Published: 24 November 2004
Free Access

Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice

Isao Sakaida,  Shuji Terai,  Naoki Yamamoto,  Koji Aoyama,  Tsuyoshi Ishikawa,  Hiroshi Nishina,  Kiwamu Okita, 
  • Pages: 1304-1311
  • First Published: 24 November 2004
Free Access

Inhibition of T-cell responses by hepatic stellate cells via B7-H1–mediated T-cell apoptosis in mice

Ming-Chin Yu,  Cheng-Hsu Chen,  Xiaoyan Liang,  Lianfu Wang,  Chandrashekhar R. Gandhi,  John J. Fung,  Lina Lu,  Shiguang Qian, 
  • Pages: 1312-1321
  • First Published: 24 November 2004
Free Access

Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice

Eyal Shteyer,  Yunjun Liao,  Louis J. Muglia,  Paul W. Hruz,  David A. Rudnick, 
  • Pages: 1322-1332
  • First Published: 24 November 2004
Free Access

Biliverdin therapy protects rat livers from ischemia and reperfusion injury

Constantino Fondevila,  Xiu-Da Shen,  Seiichiro Tsuchiyashi,  Kenichiro Yamashita,  Eva Csizmadia,  Charles Lassman,  Ronald W. Busuttil,  Jerzy W. Kupiec-Weglinski,  Fritz H. Bach, 
  • Pages: 1333-1341
  • First Published: 24 November 2004
Free Access

Role of hepatic fibrin in idiosyncrasy-like liver injury from lipopolysaccharide-ranitidine coexposure in rats

James P. Luyendyk,  Jane F. Maddox,  Christopher D. Green,  Patricia E. Ganey,  Robert A. Roth, 
  • Pages: 1342-1351
  • First Published: 24 November 2004
Free Access

Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma

Margarita Sala,  Josep M. Llovet,  Ramon Vilana,  Lluís Bianchi,  Manel Solé,  Carmen Ayuso,  Concepció Brú,  Jordi Bruix,  for the Barcelona Cly'nic Liver Cancer (BCLC) Group , 
  • Pages: 1352-1360
  • First Published: 24 November 2004
Free Access

Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen

Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire (GRETCH) , 
  • Pages: 1361-1369
  • First Published: 24 November 2004
Free Access

Low-grade steatosis and major changes in portal flow as new prognostic factors in steroid-treated alcoholic hepatitis

Christophe Duvoux,  Catherine Radier,  Françoise Roudot-Thoraval,  François Maille,  Marie-Christine Anglade,  Jeanne Tran Van Nhieu,  Isabelle Rosa,  Sylvie Hospitel,  Issam Abd-Alsamad,  Véronique Sitruk,  Olivier Seror,  Marianne Ziol,  Hughes Blondon,  Daniel Dhumeaux,  Jean-Philippe Richardet, 
  • Pages: 1370-1378
  • First Published: 24 November 2004
Free Access

Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: A randomized placebo-controlled trial

Martti Färkkilä,  Anna-Liisa Karvonen,  Heimo Nurmi,  Hannu Nuutinen,  Matti Taavitsainen,  Pekka Pikkarainen,  Päivi Kärkkäinen, 
  • Pages: 1379-1386
  • First Published: 24 November 2004
Free Access

Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

Jeffrey D. Browning,  Lidia S. Szczepaniak,  Robert Dobbins,  Pamela Nuremberg,  Jay D. Horton,  Jonathan C. Cohen,  Scott M. Grundy,  Helen H. Hobbs, 
  • Pages: 1387-1395
  • First Published: 24 November 2004
Free Access

Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score

Masatoshi Kudo M.D., Ph.D.,  Hobyung Chung,  Seiji Haji,  Yukio Osaki,  Hiroko Oka,  Toshihito Seki,  Hiroshi Kasugai,  Yo Sasaki,  Takashi Matsunaga, 
  • Pages: 1396-1405
  • First Published: 24 November 2004
Free Access

Glutathione S-transferase and liver function in intrahepatic cholestasis of pregnancy and pruritus gravidarum

Anthony T. Dann,  Anna P. Kenyon,  Paul T. Seed,  Lucilla Poston,  Andrew H. Shennan,  Rachel M. Tribe, 
  • Pages: 1406-1414
  • First Published: 24 November 2004
Free Access

Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination

Chun-Yi Lu,  Bor-Luen Chiang,  Wei-Kuang Chi,  Mei-Hwei Chang,  Yen-Hsuan Ni,  Hsu-Mei Hsu,  Shiing-Jer Twu,  Ih-Jen Su,  Li-Min Huang,  Chin-Yun Lee, 
  • Pages: 1415-1420
  • First Published: 24 November 2004
Free Access

Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection†

Florian van Bömmel,  Thomas Wünsche,  Stefan Mauss,  Petra Reinke,  Alexandra Bergk,  Dirk Schürmann,  Bertram Wiedenmann,  Thomas Berg, 
  • Pages: 1421-1425
  • First Published: 24 November 2004
Free Access

Progression of liver fibrosis in women infected with hepatitis C: Long-term benefit of estrogen exposure

Vincent Di Martino,  Pascal Lebray,  Robert P. Myers,  Emmanuelle Pannier,  Valérie Paradis,  Frédéric Charlotte,  Joseph Moussalli,  Dominique Thabut,  Catherine Buffet,  Thierry Poynard, 
  • Pages: 1426-1433
  • First Published: 24 November 2004
Free Access

Chronic hepatitis C virus infection: Does it really impact health-related quality of life? A study in rural Egypt

Michaël Schwarzinger,  Sahar Dewedar,  Claire Rekacewicz,  Khaled Mahmoud Abd Elaziz,  Arnaud Fontanet,  Fabrice Carrat,  Mostafa Kamal Mohamed, 
  • Pages: 1434-1441
  • First Published: 24 November 2004
Free Access

Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels

Bernd Kronenberger,  Eva Herrmann,  Florence Micol,  Michael von Wagner,  Stefan Zeuzem, 
  • Pages: 1442-1449
  • First Published: 24 November 2004
Free Access

Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy

Paul J. Pockros M.D.,  Mitchell L. Shiffman,  Eugene R. Schiff,  Mark S. Sulkowski,  Zobair Younossi,  Douglas T. Dieterich,  Teresa L. Wright,  Samir H. Mody,  K. Linda Tang,  Betty L. Goon,  Peter J. Bowers,  Gerhard Leitz,  Nezam H. Afdhal,  PROACTIVE Study Group , 
  • Pages: 1450-1458
  • First Published: 24 November 2004

Hepatology Elsewhere

Free Access

Cellular immune responses against HCV: T cells take a diversion in the liver

Paul Klenerman M.R.C.P.,  Nasser Semmo M.D.,  Scott Ward Ph.D., 
  • Pages: 1459-1461
  • First Published: 24 November 2004
Free Access

Editing HBV into oblivion

Simon Wain-Hobson D.Phil.,  Jean-Pierre Vartanian Ph.D., 
  • Pages: 1461-1464
  • First Published: 24 November 2004

Special Article

Free Access

AASLD single-topic research conference on hepatocellular carcinoma: Conference proceedings

Morris Sherman,  Andrew Klein, 
  • Pages: 1465-1473
  • First Published: 24 November 2004

Correspondence

Free Access

Contrast medium-associated renal dysfunction in patients with cirrhosis

Teh-Ia Huo,  Jaw-Ching Wu,  Shou-Dong Lee, 
  • Page: 1474
  • First Published: 24 November 2004
Free Access

Contrast medium-associated renal dysfunction in patients with cirrhosis

Mónica Guevara,  Gloria Fernández-Esparrach,  Pere Ginès, 
  • Page: 1474
  • First Published: 24 November 2004
Free Access

Relationship between hepatic enzymes and insulin resistance syndrome markers in HIV with lipodystrophy

Gabriela De Larrañaga,  Silvia Perés,  Jorge Benetucci, 
  • Pages: 1475-1476
  • First Published: 24 November 2004
Free Access

TIPS versus paracentesis for the treatment of refractory ascites

Albert Lau M.D.,  Curt Bay Ph.D.,  Abdul Nadir M.D., 
  • Page: 1476
  • First Published: 24 November 2004
Free Access

TIPS versus paracentesis for the treatment of refractory ascites

Francesco Salerno M.D.,  Massimo Cazzaniga M.D., 
  • Pages: 1476-1477
  • First Published: 24 November 2004

Landmarks In Hepatology

Free Access

Au Conntraire, professeur Pasteur!

Adrian Reuben MBBS, FRCP, 
  • Pages: 1478-1482
  • First Published: 24 November 2004

Correction

Free Access

Correction

  • Page: 1483
  • First Published: 24 November 2004